KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 192 filers reported holding KITE PHARMA INC in Q4 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $15,218,000 | -15.1% | 146,791 | -35.8% | 0.35% | -19.3% |
| Q1 2017 | $17,935,000 | +99.9% | 228,500 | +14.2% | 0.43% | +88.2% |
| Q4 2016 | $8,973,000 | -19.7% | 200,111 | +0.1% | 0.23% | -28.8% |
| Q3 2016 | $11,172,000 | +11.7% | 200,000 | 0.0% | 0.32% | +15.9% |
| Q2 2016 | $10,000,000 | +8.9% | 200,000 | 0.0% | 0.28% | -1.8% |
| Q1 2016 | $9,182,000 | +49.0% | 200,000 | +100.0% | 0.28% | +59.7% |
| Q4 2015 | $6,162,000 | – | 100,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |